# SPT Screening in Irradiated Hereditary Retinoblastoma Survivors

> **NCT02329002** · — · UNKNOWN · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 400 (estimated)

## Conditions studied

- Retinoblastoma

## Interventions

- **DEVICE:** Magnetic resonance imaging

## Key facts

- **NCT ID:** NCT02329002
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2018-10
- **Final completion:** 2023-10
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2014-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02329002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02329002, "SPT Screening in Irradiated Hereditary Retinoblastoma Survivors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02329002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*